Andrew Morris

Andrew Morris has a diverse work experience in the medical device industry. Andrew currently serves as the Director of Engineering, Advanced Technology at Alphatec Spine since September 2022. Prior to this, they were the Director of Mechanical Engineering at INOVIO Pharmaceuticals, Inc. from February 2021 to September 2022.

Andrew also worked at Dexcom from September 2018 to February 2021, where they held multiple roles including Director of Mechanical R&D - Process Design & Development, and Sr. Manager, R&D Process Development.

Earlier in their career, Andrew held various managerial positions at NuVasive from February 2014 to August 2018, including Sr. Engineering Manager and Sr. Manager of Product Development Engineering.

Before that, Andrew worked at REVA Medical, Inc. as a Manager of Engineering Development from February 2002 to January 2009, contributing to the development of bioresorbable drug-loaded cardiovascular and peripheral stents. Andrew also worked as a Sr. Process Engineer at Nitinol Devices & Components, Inc. from February 1999 to June 2001, where they played a role in the development and production of self-expanding stents made of Nitinol.

Throughout their career, Andrew has demonstrated their expertise in engineering, product development, project management, and team leadership within the medical device industry.

Andrew Morris attended California Polytechnic State University-San Luis Obispo from 1993 to 1998, where they earned a Bachelor's degree in Mechanical Engineering. No additional information is provided regarding their field of study.